Scientific leaders in the fight against viral diseases.

Our medicinal chemistry and virology expertise, bolstered by our collective experience in drug development, is enabling us to pioneer new advancements in antiviral science.

A scientist looking through the binoculars of a stereomicroscope.

Potentially transforming the treatment of severe viral infections.

Leveraging the power of our medicinal chemistry expertise and purine nucleotide prodrug platform, we are focused on discovering, optimizing, and rapidly advancing novel drug candidates for viral targets such as SARS CoV-2.